STERIS is a global leader in infection prevention, contamination control, surgical technologies, and more.
STERIS is the world’s pre-eminent infection prevention, decontamination, and surgical and critical care company, with a long list of first-to-market products and industry-leading service innovations and thousands of customers in more than 60 countries.
While the corporation was founded as Innovative Medical Technologies in 1985 and renamed STERIS in 1987, our history dates back to 1894 with the founding of American Sterilizer Company, a long-time, global leading innovator of sterilization products.
Today, through a series of strategic acquisitions and continual innovation of new products, STERIS holds one of the broadest portfolios of products in the industry. It stands at the forefront of efforts to prevent infection and contamination in healthcare and pharmaceutical environments, and is broadening its reach with products to meet the needs of defense and industrial markets.
STERIS was founded in 1987 and is headquartered in Mentor, US
Report incorrect company information
STERIS Office Locations
STERIS has an office in Mentor
Mentor, US (HQ)
5960 Heisley Rd
Mentor, US
9260 Progress Pkwy
Report incorrect company information
STERIS Financials and Metrics
STERIS Financials
STERIS's revenue was reported to be $2.61 b in FY, 2017 which is a 16.7% increase from the previous period.
| USD | |
|---|---|
Revenue (Q1, 2018) | 608 m |
Gross profit (Q1, 2018) | 256.1 m |
Gross profit margin (Q1, 2018), % | 42.1% |
Net income (Q1, 2018) | 58.2 m |
EBIT (Q1, 2018) | 86.3 m |
Market capitalization (21-May-2018) | 8.9 b |
Closing share price (21-May-2018) | 104.7 |
Cash (30-Jun-2017) | 294.8 m |
STERIS's current market capitalization is $8.9 b.
- Source: SEC Filings
Annual
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|
Revenue | 1.6 b | 1.9 b | 2.2 b | 2.6 b |
Revenue growth, % | 14% | 21% | 17% | |
Cost of goods sold | 972.6 m | 1.1 b | 1.3 b | 1.6 b |
Gross profit | 649.6 m | 774.3 m | 895.5 m | 1 b |
Quarterly
| USD | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 |
|---|---|---|---|---|---|
Revenue | 618.7 m | 638.4 m | 646.4 m | 646.8 m | 608 m |
Cost of goods sold | 380.5 m | 398.4 m | 398.5 m | 389.2 m | 351.8 m |
Gross profit | 238.2 m | 240 m | 247.9 m | 257.6 m | 256.1 m |
Gross profit Margin, % | 38% | 38% | 38% | 40% | 42% |
- Source: SEC Filings
Annual
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|
Cash | 152.8 m | 167.7 m | 248.8 m | 282.9 m |
Accounts Receivable | 313.7 m | 325.3 m | 471.5 m | 483.5 m |
Inventories | 37 m | 35 m | 59.4 m | 197.8 m |
Current Assets | 674.7 m | 720.4 m | 972.5 m | 1 b |
Quarterly
| USD | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 |
|---|---|---|---|---|---|
Cash | 231.4 m | 242.4 m | 254.4 m | 264.9 m | 294.8 m |
Accounts Receivable | 440.9 m | 439.8 m | 441.3 m | 443.7 m | 455.6 m |
Inventories | 208.3 m | 209.6 m | 209.9 m | 209.7 m | 217.4 m |
Current Assets | 965.7 m | 945.9 m | 956.2 m | 970.3 m | 1 b |
Annual
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|
Net Income | 129.4 m | 135.1 m | 110.8 m | 110 m |
Accounts Payable | 19.4 m | (3.1 m) | 5.2 m | 6.9 m |
Cash From Operating Activities | 209.6 m | 246 m | 81.2 m | 424.1 m |
Cash From Investing Activities | (148.7 m) | (283.8 m) | (729.6 m) | (104.3 m) |
Quarterly
| USD | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 |
|---|---|---|---|---|---|
Net Income | 20 m | 48.4 m | 88.9 m | 84.6 m | 58.2 m |
Accounts Payable | (17.9 m) | (13.2 m) | (17 m) | (5.8 m) | (10.2 m) |
Cash From Operating Activities | 104.6 m | 80.3 m | 188.5 m | 289.4 m | 80.7 m |
Cash From Investing Activities | (686.4 m) | (35.6 m) | (8.7 m) | (42.9 m) | (54.9 m) |
| USD | Y, 2017 |
|---|---|
Financial Leverage | 1.7 x |
STERIS Operating Metrics
| FY, 2016 | |
|---|---|
Patents (US) | 390 |
Patents (foreign) | 1.10 k |
Patents Pending | 470 |
Report incorrect company information
STERIS News and Updates
April 09, 2018
Forecast on Endoscope Detergents And Disinfectants Market for the Period 2017 – 2027
Future Market Insights has announced the addition of the “Endoscope Detergents And Disinfectants Market Global Industry Analysis and Opportunity Assessment, 2017 - 2027"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
March 22, 2018
Operation Theatre Lights Market Will Generate New Growth Opportunities By 2025
Cavities in the human body are dark and can obstruct the visualization of lesions and minute body parts, making the surgical procedure difficult. Posted via Industry Today. Follow us on Twitter @IndustryToday
January 02, 2018
Disinfectant Cleaner Market 2017 Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast to 2022
Wiseguyreports.Com adds “Disinfectant Cleaner Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday
December 18, 2017
Surgical Tables Market Anticipated to Cross US$1,014.3 Mn by 2022
According to Transparency Market Research, the global surgical tables market was valued at US$837.1 mn in 2017 and is expected to rise to US$1,014.3 mn by 2022 at a steady 4.1% CAGR therein. Posted via Industry Today. Follow us on Twitter @IndustryToday
December 13, 2017
Global Surgical Drapes Market to Record a Sluggish CAGR of 3.3% during 2017 and 2025
Global Surgical Drapes Market: Need for Effective Methods of Preventing SSIs and HAIs to Fuel Demand. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information